Kalshi and Polymarket Face Criticism Over Clinical Trial Betting Markets
Prediction market platforms Kalshi and Polymarket launched contracts allowing users to wager on clinical trial outcomes and Food and Drug Administration drug approvals. While proponents argue the markets provide transparent data, researchers and patients condemn the financial incentives as threatening trial integrity and mocking patient suffering. Prediction markets have rapidly expanded into sports, elections, and … Read more